Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson's disease by regulating gut microbiota
点击查看 >>
Author:
Wang Y; Tong Q; Ma SR; Zhao ZX; Pan LB; Cong L; Han P; Peng R; Yu H; Lin Y; Gao TL; Shou JW; Li XY; Zhang XF; Zhang ZW; Fu J; Wen BY; Yu JB; Cao X; Jiang JD.
Publish_to:
Signal Transduction and Targeted Therapy
Free Cholesterol-Induced Liver Injury in Non-Alcoholic Fatty Liver Disease: Mechanisms and a Therapeutic Intervention Using Dihydrotanshinone I
点击查看 >>
Author:
Jia-Wen Shou, Juncai Ma, Xuchu Wang, Xiao-Xiao Li, Shu-Cheng Chen, Byung-Ho Kang, Pang-Chui Shaw
Publish_to:
Advanced Science
Gut microbiota mediates the absorption of FLZ, a new drug for Parkinson's disease treatment
点击查看 >>
Author:
Junmei Shang, Shurong Ma, Caixia Zang, Xiuqi Bao, Yan Wang, Dan Zhang
Publish_to:
Acta Pharmaceutica Sinica B
Gut microbiota-based PK-PD study and molecular mechanism of Specnuezhenide in the treatment of colorectal cancer targeting carboxylesterase
点击查看 >>
Author:
Hang Yu, Hui Xu, Xinyu Yang, Zhengwei Zhang, Jiachun Hu, Jinyue Lu, Jie Fu, Mengmeng Bu, Haojian Zhang, Zhao Zhai, Jingyue Wang, Jiandong Jiang, Yan Wang
Publish_to:
Journal of Pharmaceutical Analysis
Berberine activates PPARδ and promotes gut microbiota-derived butyric acid to suppress hepatocellular carcinoma
点击查看 >>
Author:
Jia-Wen Shou, Pang-Chui Shaw
Publish_to:
PHYTOMEDICINE